Cartia XT — Class II drug recall D-0232-2022
Terminated recall by Teva Pharmaceuticals USA, reported 2021-11-24, distributed nationwide. Labelling: Incorrect Exp. Date
| Recall number | D-0232-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Parsippany, NJ, United States |
| Recall initiated | 2021-10-27 |
| Classified | 2021-11-15 |
| Reported by FDA | 2021-11-24 |
| Terminated | 2022-12-21 |
| Distributed | Nationwide (US) |
| Quantity | 32,316 bottles |
| NDC | 62037-0597, 62037-0597-05, 62037-0597-90, 62037-0598, 62037-0598-05, 62037-0598-90, 62037-0599, 62037-0599-05, 62037-0599-90, 62037-0600, 62037-0600-05, 62037-0600-90 |
| Lot numbers | 100023805 |
| Expiration dates | 2023-05 |
Product
Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054; (b) Manufactured By: Actavis Laboratories FL. Inc, Fort Lauderdale FL. 33314 USA, Distributed by Avista Pharma Inc. Parsippany, NJ 07054 USA. NDC 62037-597-90
Reason for recall
Labelling: Incorrect Exp. Date
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0232-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.